Intersurgical CEO Sigitas Žvirblis has told BNS that the production facility in Pabradė, some 50 kilometers from Vilnius, currently employs more than 1,500 people. He said that the company needs a qualified labor force, which is not available in the town, for further expansion.
"We see no room for expansion (in Pabradė). I am speaking about qualified labor force problems, rather than about the production area. The company is growing by 6 to 8 percent on average annually. We need to plan our production capacities in advance, which is impossible," Žvirblis told BNS.
"We chose Alytus because of the two key advantages: its qualified labor force and well-developed social infrastructure," he added.
The company plans to invest an estimated 50 million litas (EUR 14.5m) at this stage and create up to 100 new jobs. It expects the new plant to start operating in early 2014.
Intersurgical considered foreign expansion, in China or Poland, but chose Lithuania, the CEO said.
The company, which specializes in the manufacturing of disposable respiratory care products, exports its products to more than 100 countries.
